ScienceMore in Science→
DoriVac: DNA Origami Vaccines Could Surpass mRNA Technology
Scientists have developed DoriVac, a DNA nanostructure vaccine platform producing stronger and more durable immune responses than mRNA vaccines in early studies, with applications targeting HIV, Ebola, and COVID-19.
Key Takeaways
- DoriVac uses folded DNA nanostructures to present antigens in ordered arrays that mimic actual virus surfaces, boosting immune response
- Early studies show stronger antibody AND T cell responses compared to conventional approaches
DE
DT Editorial Team··3 min read·via sciencedaily.com